Navigation path

Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Lentiviral vector containing the human Wiskott Aldrich syndrome protein gene

EU orphan designation number: EU/3/05/345
Active ingredient: Lentiviral vector containing the human Wiskott Aldrich syndrome protein gene
Indication: Treatment of Wiskott-Aldrich syndrome
Sponsor: Généthon
1 bis rue de l’internationale, F-91000 Evry, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
26/01/2006 Orphan Designation EMEA/OD/087/05 (2006)208 of 24/01/2006
02/05/2014 Removal of orphan designation from Community Register